The Technical Analyst
Select Language :
CTI Biopharma Corp [CTIC]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

CTI Biopharma Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

CTI Biopharma Corp is listed at the  Exchange

0.06% $9.10

America/New_York / 23 jun 2023 @ 15:58


CTI Biopharma Corp: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 199.45 mill
EPS: -0.540
P/E: -16.84
Earnings Date: Aug 07, 2023
SharesOutstanding: 131.88 mill
Avg Daily Volume: 5.66 mill
RATING 2023-06-23
C+
Sell
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Buy
Return On Asset: Strong Sell
DE: Strong Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
4/211/222/223/224/221/23
Revenuen/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -16.84 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-2.87x
Company: PE -16.84 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 8.91 - 9.27

( +/- 2.01%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-06-26 Bvf Partners L P/il Sell 43 139 Common Stock, par value $0.001
2023-06-26 Bvf Partners L P/il Sell 12 Series X Convertible Preferred Stock
2023-06-26 Bvf Partners L P/il Sell 17 Series X1 Convertible Preferred Stock
2023-06-26 Bvf Partners L P/il Sell 120 000 Stock Option (Right to Buy)
2023-06-26 Bvf Partners L P/il Sell 60 000 Stock Option (Right to Buy)
INSIDER POWER
-81.30
Last 99 transactions
Buy: 2 253 317 | Sell: 15 023 868

Forecast: 01:40 - $8.59

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $9.10 (0.06% )
Volume 5.56 mill
Avg. Vol. 5.66 mill
% of Avg. Vol 98.18 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for CTI Biopharma Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for CTI Biopharma Corp

RSI

Intraday RSI14 chart for CTI Biopharma Corp

Last 10 Buy & Sell Signals For CTIC

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            CTI Biopharma Corp

CTIC

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

Last 10 Buy Signals

Date Signal @
SEIUSDMar 28 - 18:020.860
LQTYUSDMar 28 - 18:021.425
FLOWUSDMar 28 - 18:02$1.388
BATUSDMar 28 - 18:02$0.333
PEOPLEUSDMar 28 - 17:590.0398
MBOXUSDMar 28 - 17:580.473
GALXUSDMar 28 - 17:585.08
^NYAMar 28 - 17:40PTS18 255
RBTCUSDMar 28 - 17:57$70 251
ORNUSDMar 28 - 17:59$2.31

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.